Published in Exp Ther Med on December 15, 2014
Pentoxifylline inhibits pulmonary inflammation induced by infrarenal aorticcross-clamping dependent of adenosine receptor A2A. Am J Transl Res (2016) 0.75
Histopathological Evaluation of Contrast-Induced Acute Kidney Injury Rodent Models. Biomed Res Int (2016) 0.75
Atorvastatin alleviates iodinated contrast media-induced cytotoxicity in human proximal renal tubular epithelial cells. Exp Ther Med (2017) 0.75
Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med (2003) 5.17
Pentoxifylline. J Am Acad Dermatol (1994) 3.52
Canadian Association of Radiologists: consensus guidelines for the prevention of contrast-induced nephropathy. Can Assoc Radiol J (2007) 3.48
Contrast-induced kidney injury: mechanisms, risk factors, and prevention. Eur Heart J (2012) 1.80
NADPH oxidase p22phox and catalase gene variants are associated with biomarkers of oxidative stress and adverse outcomes in acute renal failure. J Am Soc Nephrol (2006) 1.46
Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure. J Am Soc Nephrol (1995) 1.36
In vivo and in vitro assessment of pathways involved in contrast media-induced renal cells apoptosis. Cell Death Dis (2011) 1.00
Clinical and experimental evidence for prevention of acute renal failure induced by radiographic contrast media. J Pharmacol Sci (2005) 0.99
Protective effect of apocynin, a NADPH-oxidase inhibitor, against contrast-induced nephropathy in the diabetic rats: a comparison with n-acetylcysteine. Eur J Pharmacol (2011) 0.92
Pathogenesis of contrast-induced nephropathy: experimental and clinical observations with an emphasis on the role of osmolality. Rev Cardiovasc Med (2003) 0.90
Efficacy of pentoxifylline in prevention of contrast-induced nephropathy in angioplasty patients. Int Urol Nephrol (2011) 0.89
Pentoxifylline diminishes the oxidative damage to renal tissue induced by streptozotocin in the rat. Exp Diabesity Res (2005) 0.88
Prevention of hepatorenal syndrome in patients with cirrhosis and ascites: a pilot randomized control trial between pentoxifylline and placebo. Eur J Gastroenterol Hepatol (2011) 0.87
Pentoxifylline prevents the meglumine antimonate-induced renal toxicity in rats, but not that induced by the inorganic antimony pentachloride. Toxicology (2007) 0.83
Comparative cytotoxicity of high-osmolar and low-osmolar contrast media on HKCs in vitro. J Nephrol (2006) 0.83
Dietary hypercholesterolemia aggravates contrast media-induced nephropathy. Chin Med J (Engl) (2004) 0.82
Protective effect of pentoxifylline on contrast induced nephropathy. Saudi J Kidney Dis Transpl (2008) 0.82
A review of the potential protective effects of pentoxifylline against drug-induced nephrotoxicity. Eur J Clin Pharmacol (2012) 0.82
Effects of short- and long-term hypercholesterolemia on contrast-induced acute kidney injury. Am J Nephrol (2011) 0.82
Mitochondria-targeted peptides prevent on contrast-induced acute kidney injury in the rats with hypercholesterolemia. Ren Fail (2013) 0.81
Aged rats are susceptible to nephrotoxicity induced by iodinated contrast media. Ren Fail (2012) 0.81
Pentoxifylline modulates p47phox activation and downregulates neutrophil oxidative burst through PKA-dependent and -independent mechanisms. Immunopharmacol Immunotoxicol (2010) 0.81
The renoprotective potential of pentoxifylline in chronic kidney disease. J Chin Med Assoc (2005) 0.81
Nephroprotective effects of pentoxifylline in experimental myoglobinuric acute renal failure. Pathol Biol (Paris) (2002) 0.80